Updated:
Full-Life Technologies Co. Ltd.
Full-Life Technologies Co. Ltd. is based in Shanghai; the profile covers headquarters, registration, AUM band and key contacts for private-markets fundraising.
Overview
Full-Life Technologies Limited is a fully integrated global radiotherapeutics company headquartered in Shanghai, China with operations in Europe.
General information
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Additional offices
Gembloux, Belgium · Heidelberg, Germany
Principals
Debora Barton
Chief Medical Officer
Sector focus
Frequently asked questions
What investment stages does Full-Life Technologies typically target?
Full-Life focuses on preclinical through clinical-stage development of radiotherapeutics. Its pipeline includes candidates at research and clinical stages, such as FL-031 and FL-801 presented at AACR 2025. The firm does not publicly specify funding rounds or revenue stage.
Which sectors does Full-Life Technologies explicitly avoid?
Full-Life Technologies confines its activities to radiotherapeutics and oncology. It does not publicly state any excluded sectors beyond this focus.
How does Full-Life Technologies' radiotechnology platform differ from conventional biotech?
Full-Life integrates production and logistics of radiopharmaceuticals alongside drug development, a structure that reduces supply chain dependencies. The firm also operates expanded access and medical affairs functions for global regulatory compliance (per the firm).
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: